US Drug Recall Register
Class III · Low risk Ongoing Initiated Aug 14, 2023 (3 years ago)

Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Subpotent: Out of Specification for Assay Test at the 3-month time point.

What was recalled

Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale -Bardez, Goa 403513, India, Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-295-01

Recalling firm
Glenmark Pharmaceuticals Inc., USA
NDC code
68462-295-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1095-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all